4//SEC Filing
Simms Michael J 4
Accession 0001209191-12-019931
CIK 0001344413other
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 5:52 PM ET
Size
5.5 KB
Accession
0001209191-12-019931
Insider Transaction Report
Form 4
Simms Michael J
SVP, Operations & Manufact
Transactions
- Award
Common Stock
2012-03-23+46,222→ 125,825 total
Footnotes (2)
- [F1]Represents shares issued as restricted stock units (an "RSU") under the Issuer's 2005 Equity Incentive Plan (the "Plan"). The RSU will vest in full on the earlier of June 5, 2012 or a Change in Control (as defined in the Plan), provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time.
- [F2]Includes 45,582 RSUs previously reported as holdings of the Reporting Person granted under the Plan pursuant to the terms of the Issuer's 2009-2010 Performance Based Incentive Program (the "Performance Program"). The RSU will vest, and shares will be delivered to the Reporting Person, on the date the U.S. Food and Drug Administration approves the Issuer's New Drug Application for its ADASUVE (Staccato? loxapine) product candidate, if ever, provided that at the relevant vesting date the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
Documents
Issuer
Alexza Pharmaceuticals Inc.
CIK 0001344413
Entity typeother
Related Parties
1- filerCIK 0001427117
Filing Metadata
- Form type
- 4
- Filed
- Mar 25, 8:00 PM ET
- Accepted
- Mar 26, 5:52 PM ET
- Size
- 5.5 KB